#VisualAbstract: Ruxolitinib use may be associated with higher incidences of nonmelanoma skin cancers
Click to read this study in the Journal of the American Academy of Dermatology.
Click to read this study in the Journal of the American Academy of Dermatology.
Click to read this study in the Journal of the American Academy of Dermatology.
Click to read the study in the Journal of the American Academy of Dermatology.
Click to read the study in The Lancet Oncology.
Click to read the study in the Journal of the American Academy of Dermatology.
Click to read the study in the Journal of the American Academy of Dermatology.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.